°ÄÃÅÁùºÏ²Ê¿ª½±¼Ç¼

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Antibodies & Complement: Effector Functions, Therapies & Technologies

20 June 2017 16:00 - 23 June 2017 12:30, Olhão, Portugal


Introduction
The antibody response and the complement system are major effector arms of the immune system. Both have been involved in a plethora of pathological conditions – including autoimmunity, allergy, infections and cancer- and regulate, mainly through their receptors (FcR and CR respectively) cell activation, migration, survival but also metabolism. As the portfolio of antibody- and complement-effector function grow, high-end technological solutions are developed and novel therapeutic applications are proposed.

This Zing conference will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts. Some of the critical topics to be covered include

Antibody & complement functions
FcR and CR
Ab glycosylation and anti-inflammatory activity

Structure – function linkage
Novel technologies
Complement and antibody therapies

This Antibody & Complement meeting will be a forum for leaders in the field and new investigators coming from academia, industry and research institutes to discuss where the field is going and what challenges lie ahead.
Speakers
Venue
Real Marina Hotel and Spa

Real Marina Hotel and Spa, Av. 5 de Outubro, Olhão, 8700-307, Portugal

Useful links

Organised by

Contact information
Zing Conferences C.I.C.
Office Suite L17 & L24,
South Fens Business Centre,
Fenton Way,
Chatteris,
Cambridgeshire,
PE16 6TT,
UK
+44 1223750020
Contact us by email

Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*